Slovak Chem/Pharma Production

7 July 1996

In Slovakia, the Union of the Chemical and Pharmaceutical Industries says the two industries manufactured goods worth 75 billion korune ($2.4 billion) in 1995, 78% of which were exported, reports CTK Business News. Chemicals and drugs account for 24.5% of total Slovak exports, and their share of revenues to the state budget exceeds 25%.

- Czech and Slovak firms produced 71% of the medicines sold in the Czech Republic in the last two years, says the International Association of Pharmaceutical Companies in the Republic, and this is higher than the share held by domestic drugmakers in the UK, Spain, Germany, Belgium and other countries, reports CTK Business News.

- The number of pharmacists operating in Albania is five times than in 1992, mainly as a result of the privatization of the retail drugs sector, reports the Albanian telegraphic Agency. The number of private clinics is also rising rapidly.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight